Clark Estates »

Catalyst Pharmaceutical Partners shares owned by Clark Estates

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Clark Estates from 13F filings

Historical chart of Clark Estates investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Clark Estates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Clark Estates

Quarter filed Position value Share count Share price at filing
2024-12-31 $3.9M 186k 20.87
2024-09-30 $4.1M 208k 19.88
2024-06-30 $3.5M 225k 15.49
2024-03-31 $3.7M 231k 15.94
2023-12-31 $3.3M 198k 16.81
2023-09-30 $2.2M 188k 11.69

More positions owned by Clark Estates

Ea Series Trust Euclidean Fundam (ECML)
Dun & Bradstreet Hldgs (DNB)
Baxter International (BAX)
Medtronic SHS (MDT)
Smith & Nephew Spdn Adr New (SNN)
Haleon Spon Ads (HLN)
Kenvue (KVUE)
Sony Group Corp Sponsored Adr (SONY)
Unilever Spon Adr New (UL)
Fiserv (FI)
Diageo Spon Adr New (DEO)
Bausch Plus Lomb Corp Common Shares (BLCO)
Philip Morris International (PM)
Ge Healthcare Technologies I Common Stock (GEHC)
L3harris Technologies (LHX)

View all positions for Clark Estates

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
State Street Corporation
Deerfield Management Company
Dimensional Fund Advisors
Pacer Advisors
Goldman Sachs Group
Renaissance Technologies
Geode Capital Management
First Trust Advisors
Morgan Stanley
Royce & Associates
Bank of America Corporation
Northern Trust
Nuveen Asset Management

View all funds holding Catalyst Pharmaceutical Partners